Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. 1995

A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
Department of Medicine, Medical University of South Carolina, Charlestown 29425, USA.

OBJECTIVE Systemic sclerosis (scleroderma, SSc) frequently affects the lungs, and interstitial pulmonary fibrosis is one of its major complications. The pathophysiology of SSc lung disease s poorly understood, but recent studies document an inflammatory process resembling that of idiopathic pulmonary fibrosis with increased numbers of activated alveolar macrophages and granulocytes in bronchoalveolar lavage (BAL) fluid). We determined levels of 2 potentially important mediators of fibroproliferative repair in BAL fluid from patients with SSc. METHODS Using Western blot and ELISA techniques we measured levels of platelet derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta in BAL fluid from patients with SSc and healthy controls. The mitogenic effect of these cytokines on SSc lung myofibroblasts was determined by [3H]thymidine incorporation. RESULTS SSc BAL fluid contains significantly elevated levels of PDGF-AA and PDGF-BB. Where TGF-beta 1 was significantly elevated in SSc lavage fluid, the amount of TGF-beta 2 was significantly less than that observed in normal lavage fluid. Myofibroblasts cultured from SSc lavage fluid exhibited enhanced [3H]thymidine incorporation upon exposure to the growth factors present in SSc BAL fluid: PDGF and TGF-beta 1. SSc lung myofibroblasts pretreated with TGF-beta 1 exhibited an enhanced mitogenic effect upon stimulation by PDGF, due in part to the induction of the PDGF alpha receptor. CONCLUSIONS Our studies support a role for PDGF and TGF-beta 1 in the pathogenesis of SSc lung disease.

UI MeSH Term Description Entries
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
November 2009, Pediatric pulmonology,
A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
August 1997, American journal of respiratory and critical care medicine,
A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
August 1998, American journal of respiratory and critical care medicine,
A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
February 1997, The Tohoku journal of experimental medicine,
A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
December 2003, Biomedica : revista del Instituto Nacional de Salud,
A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
June 2003, Arthritis and rheumatism,
A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
March 1993, Sarcoidosis,
A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
July 2000, Transplantation,
A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
March 2005, Annals of the rheumatic diseases,
A Ludwicka, and T Ohba, and M Trojanowska, and A Yamakage, and C Strange, and E A Smith, and E C Leroy, and S Sutherland, and R M Silver
April 1997, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!